Three things to know:
1. Previously Mr. Lemaitre served as CEO of CoreValve, which was acquired by Medtronic for $800 million in 2009, and chairman of Bioventus, according to his LinkedIn.
2. He operated as Medtronic’s senior vice president of strategy and business development before the CoreValve acquisition.
3. BlueWind develops implantable neurostimulators for the spinal cord, deep brain and occipital nerve, according to its website.
More articles on devices:
Orthopedic clinic faces renewed lawsuit over 2016 cyberattack
Orthopedics unit restructures workforce to boost efficiency — 5 details
Optim Orthopedics performs four free joint replacements
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.